Skip to content

Investment firm secures $27 million during Series A round

Investment firm E14 Fund bolsters Overjet's Series A funding, having previously supported the company in its seed round.

Funding Event: Series A Raises $27 Million by Overjet
Funding Event: Series A Raises $27 Million by Overjet

Investment firm secures $27 million during Series A round

Overjet, a US-based company specialising in artificial intelligence (AI) technology for dentistry, has secured $27 million in a series A funding round. This significant investment follows a seed round of nearly $7.9 million raised in June 2020.

Crosslink Capital led the seed round, with participation from unnamed industry partners and the E14 Fund, a vehicle focused on companies linked to Massachusetts Institute of Technology (MIT) Media Lab. In the series A round, Crosslink Capital also invested, joined by General Catalyst and Insight Partners who co-led the round.

The funds raised will be utilised to accelerate the adoption and facilitate product launches of Overjet's AI technology. This technology is designed to process dental radiographs, aiming to streamline dental procedures and improve patient care.

It's important to note that Thierry Heles, a former editor-at-large of Global University Venturing and Global Corporate Venturing, is not currently associated with Overjet. Heles was also the producer and host of the Beyond the Breakthrough podcast until its end in December 2024. The reason for the podcast's conclusion is not specified in the available information. Heles's professional background is in journalism and podcast production, not dentistry or AI.

The current location of Overjet is not available in the provided search results. However, the company's focus on AI technology for dentistry indicates a commitment to innovation and advancement in the healthcare sector.

This investment in Overjet underscores the growing interest in AI applications in various industries, particularly healthcare, and the potential for these technologies to revolutionise traditional practices and improve outcomes for patients.

Read also:

Latest